Merck's Q4 2024 results surpassed expectations, driven by strong oncology sales and growth in Keytruda. See why I think MRK ...
While Merck reported strong financial results in recent quarters, it faces both upsides and risks in the future. Read why I'm ...
If you suffered losses exceeding $100,000 in Merck between February 3, 2022 and February 3, 2025 and would like to discuss ...
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Merck & Co ("Merck" or the "Company") securities between February 3, 2022, to ...
We recently compiled a list of the Jim Cramer Remembers COVID-19 & Discusses These 11 Stocks. In this article, we are going to take a look at where Merck & Co., Inc.
Merck & Co. is facing a class action lawsuit over Gardasil sales projections. Learn how to recover losses with Levi & ...
A class action lawsuit has been filed against Merck & Co., Inc. for alleged securities fraud. The lawsuit claims that between February 3, 2022, and February 3, 2025, Merck misled investors about its ...
President Donald Trump and Elon Musk have been rapidly firing federal workers with little consideration for which ones are critical to government functioning. The Federal Aviation Administration is ...
On July 30, 2024, Merck released its second quarter 2024 financial report and disclosed a significant reduction in Gardasil vaccinations, resulting in an overabundance of inventory at Merck's Chinese ...
The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. . Shareholders who purchased shares of MRK ...
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...
Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results